노텍정(세티리진염산염)

Recall Summary Notek Tablets (cetirizine hydrochloride), a medication distributed in South Korea by Mirae Biopharmaceuticals, are being recalled due to concerns about product quality in distributed batches. The recall affects five specific product batches identified by barcodes ending in 1105, 1112, 1129, 1136, and 1143. This is classified as a Class I recall, the most serious classification level.

Recalling firm
미래바이오제약(주)
Product
노텍정(세티리진염산염) (Barcode: 8806575001105, 8806575001112, 8806575001129, 8806575001136, 8806575001143)
Reason
유통제품품질부적합우려
Classification
Class I
Category
drug recall
Country
South Korea
Agency
MFDS-DRUG
Recall date
2026-05-14
Status
Ongoing
Distribution
South Korea

Official recall notice from MFDS-DRUG

Recall details on Nibble Recalls: https://trynibble.app/recalls/c1aac5bf-b3e1-4cec-8038-6262cbb6bf93